- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 4 residues within 4Å:- Chain A: N.717, L.922, Q.926, Q.1071
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:L.922
NAG-NAG.3: 3 residues within 4Å:- Chain A: N.801, S.803, Q.804
No protein-ligand interaction detected (PLIP)NAG-NAG.4: 4 residues within 4Å:- Chain A: H.146, N.149, S.151
- Chain D: L.106
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:L.106
NAG-NAG.7: 4 residues within 4Å:- Chain F: N.717, L.922, Q.926, Q.1071
1 PLIP interactions:1 interactions with chain F- Hydrophobic interactions: F:L.922
NAG-NAG.8: 3 residues within 4Å:- Chain F: N.801, S.803, Q.804
No protein-ligand interaction detected (PLIP)NAG-NAG.9: 4 residues within 4Å:- Chain F: H.146, N.149, S.151
- Chain I: L.106
1 PLIP interactions:1 interactions with chain I- Hydrophobic interactions: I:L.106
NAG-NAG.12: 4 residues within 4Å:- Chain K: N.717, L.922, Q.926, Q.1071
1 PLIP interactions:1 interactions with chain K- Hydrophobic interactions: K:L.922
NAG-NAG.13: 3 residues within 4Å:- Chain K: N.801, S.803, Q.804
No protein-ligand interaction detected (PLIP)NAG-NAG.14: 4 residues within 4Å:- Chain K: H.146, N.149, S.151
- Chain N: L.106
1 PLIP interactions:1 interactions with chain N- Hydrophobic interactions: N:L.106
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-FUC.5: 4 residues within 4Å:- Chain A: C.15, V.16, N.17, N.137
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.137
NAG-NAG-FUC.10: 4 residues within 4Å:- Chain F: C.15, V.16, N.17, N.137
1 PLIP interactions:1 interactions with chain F- Hydrogen bonds: F:N.137
NAG-NAG-FUC.15: 4 residues within 4Å:- Chain K: C.15, V.16, N.17, N.137
1 PLIP interactions:1 interactions with chain K- Hydrogen bonds: K:N.137
- 39 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.16: 2 residues within 4Å:- Chain A: N.331, Q.580
Ligand excluded by PLIPNAG.17: 1 residues within 4Å:- Chain A: N.603
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain A: N.616, Q.644
Ligand excluded by PLIPNAG.19: 2 residues within 4Å:- Chain A: H.655, N.657
Ligand excluded by PLIPNAG.20: 2 residues within 4Å:- Chain A: N.709, G.1131
Ligand excluded by PLIPNAG.21: 4 residues within 4Å:- Chain A: A.706, E.1072, K.1073, N.1074
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain A: N.1098, T.1100, F.1103
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain A: I.1132, N.1134
Ligand excluded by PLIPNAG.24: 5 residues within 4Å:- Chain A: N.122, A.123, T.124, V.127, E.154
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain A: N.280, N.282
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain A: T.108, N.234, T.236
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain A: N.164, N.165
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain A: Y.28, N.61
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain F: N.331, Q.580
Ligand excluded by PLIPNAG.30: 1 residues within 4Å:- Chain F: N.603
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain F: N.616, Q.644
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain F: H.655, N.657
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain F: N.709, G.1131
Ligand excluded by PLIPNAG.34: 4 residues within 4Å:- Chain F: A.706, E.1072, K.1073, N.1074
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain F: N.1098, T.1100, F.1103
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain F: I.1132, N.1134
Ligand excluded by PLIPNAG.37: 5 residues within 4Å:- Chain F: N.122, A.123, T.124, V.127, E.154
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain F: N.280, N.282
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain F: T.108, N.234, T.236
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain F: N.164, N.165
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain F: Y.28, N.61
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain K: N.331, Q.580
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain K: N.603
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain K: N.616, Q.644
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain K: H.655, N.657
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain K: N.709, G.1131
Ligand excluded by PLIPNAG.47: 4 residues within 4Å:- Chain K: A.706, E.1072, K.1073, N.1074
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain K: N.1098, T.1100, F.1103
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain K: I.1132, N.1134
Ligand excluded by PLIPNAG.50: 5 residues within 4Å:- Chain K: N.122, A.123, T.124, V.127, E.154
Ligand excluded by PLIPNAG.51: 2 residues within 4Å:- Chain K: N.280, N.282
Ligand excluded by PLIPNAG.52: 3 residues within 4Å:- Chain K: T.108, N.234, T.236
Ligand excluded by PLIPNAG.53: 2 residues within 4Å:- Chain K: N.164, N.165
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain K: Y.28, N.61
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- McCallum, M. et al., N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell (2021)
- Release Date
- 2021-04-14
- Peptides
- Spike glycoprotein: AFK
S2M11 Fab Light Chain variable region: BGL
S2M11 Fab Heavy Chain variable region: CHM
S2L28 Fab Heavy Chain variable region: DIN
S2L28 Fab Light Chain variable region: EJO - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AF
BK
KB
DG
CL
LC
EH
FM
MD
HI
GN
NE
JJ
IO
O
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 39 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- McCallum, M. et al., N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell (2021)
- Release Date
- 2021-04-14
- Peptides
- Spike glycoprotein: AFK
S2M11 Fab Light Chain variable region: BGL
S2M11 Fab Heavy Chain variable region: CHM
S2L28 Fab Heavy Chain variable region: DIN
S2L28 Fab Light Chain variable region: EJO - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AF
BK
KB
DG
CL
LC
EH
FM
MD
HI
GN
NE
JJ
IO
O